The Current Ratio as of November 2024 (TTM) for Autolus Therapeutics plc (AUTL) is 13.69

According to Autolus Therapeutics plc’s latest financial reports and current stock price. The company's current Current Ratio is 13.69. This represents a change of -3.34% compared to the average of 14.16 of the last 4 quarters.

Autolus Therapeutics plc (AUTL) Historical Current Ratio (quarterly & annually)

How has AUTL Current Ratio performed in the past?

The mean historical Current Ratio of Autolus Therapeutics plc over the last ten years is 11.64. The current 13.69 Current Ratio has changed 11.66% with respect to the historical average. Over the past ten years (40 quarters), AUTL's Current Ratio was at its highest in in the June 2017 quarter at 28.31. The Current Ratio was at its lowest in in the December 2016 quarter at 0.

Autolus Therapeutics plc (AUTL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Autolus Therapeutics plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Autolus Therapeutics plc (AUTL) Average Current Ratio

How has AUTL Current Ratio performed in the past?

The current Current Ratio of Autolus Therapeutics plc (AUTL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Autolus Therapeutics plc (AUTL) Current Ratio vs. Peers

How is AUTL’s Current Ratio compared to its peers?

Autolus Therapeutics plc’s Current Ratio is less than Cullinan Oncology, Inc. (24.46), greater than Bolt Biotherapeutics, Inc. (3.16), less than Day One Biopharmaceuticals, Inc. (14.62), greater than Lyra Therapeutics, Inc. (3.64), greater than Acumen Pharmaceuticals, Inc. (10.43), greater than X4 Pharmaceuticals, Inc. (4.89), greater than Inozyme Pharma, Inc. (7.68), greater than VectivBio Holding AG (9.14), less than Terns Pharmaceuticals, Inc. (32.99), greater than Amylyx Pharmaceuticals, Inc. (4.55), less than Ikena Oncology, Inc. (15.32), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Celcuity Inc. (10.36), less than MediciNova, Inc. (16.66), less than Rezolute, Inc. (13.79), greater than Mirati Therapeutics, Inc. (7.54), greater than Apellis Pharmaceuticals, Inc. (4.36),

Build a custom stock screener for Autolus Therapeutics plc (AUTL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Autolus Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Autolus Therapeutics plc (AUTL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Autolus Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.